1150-1151 / 2063
Conclusions from EPO trials
•
RT plus EPO has a negative influence on outcome
as opposed to RT alone (non-haemopoietic effects
of EPO?)
•
EPO should not be administered as an addition to
RT outside the experimental setting for patients with
head and neck cancer.
38